These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 28875492)

  • 41. Single-Cell Proteomics for Cancer Immunotherapy.
    Li L; Yan S; Lin B; Shi Q; Lu Y
    Adv Cancer Res; 2018; 139():185-207. PubMed ID: 29941105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer, obesity and immunometabolism - Connecting the dots.
    Dyck L; Lynch L
    Cancer Lett; 2018 Mar; 417():11-20. PubMed ID: 29253522
    [No Abstract]   [Full Text] [Related]  

  • 43. The influence of microenvironment on tumor immunotherapy.
    Zhang J; Shi Z; Xu X; Yu Z; Mi J
    FEBS J; 2019 Nov; 286(21):4160-4175. PubMed ID: 31365790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D endocrinology on the cross-road between immunity and metabolism.
    Vanherwegen AS; Gysemans C; Mathieu C
    Mol Cell Endocrinol; 2017 Sep; 453():52-67. PubMed ID: 28461074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.
    Mockler MB; Conroy MJ; Lysaght J
    Front Oncol; 2014; 4():107. PubMed ID: 24904823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
    Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Metabolic Competition in Tumor Microenvironment].
    Eikawa S; Udono H
    Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic adaptation of lymphocytes in immunity and disease.
    Chapman NM; Chi H
    Immunity; 2022 Jan; 55(1):14-30. PubMed ID: 35021054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy.
    Lin Y; Zhou X; Ni Y; Zhao X; Liang X
    Front Immunol; 2022; 13():1030831. PubMed ID: 36311734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy.
    Sheppard AD; Lysaght J
    Methods Mol Biol; 2020; 2184():233-263. PubMed ID: 32808230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diverse macrophages polarization in tumor microenvironment.
    Rhee I
    Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic regulation of innate immunity.
    Liang S; Ji L; Kang L; Hu X
    Adv Immunol; 2020; 145():129-157. PubMed ID: 32081196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. γδ T Cells: Unexpected Regulators of Cancer Development and Progression.
    Fleming C; Morrissey S; Cai Y; Yan J
    Trends Cancer; 2017 Aug; 3(8):561-570. PubMed ID: 28780933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
    Gentric G; Mieulet V; Mechta-Grigoriou F
    Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic regulation of immune responses: therapeutic opportunities.
    Assmann N; Finlay DK
    J Clin Invest; 2016 Jun; 126(6):2031-9. PubMed ID: 27249676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy.
    Sethi V; Vitiello GA; Saxena D; Miller G; Dudeja V
    Gastroenterology; 2019 May; 156(7):2097-2115.e2. PubMed ID: 30768986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer.
    Audrito V; Managò A; Gaudino F; Sorci L; Messana VG; Raffaelli N; Deaglio S
    Front Immunol; 2019; 10():1720. PubMed ID: 31402913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says "NO" to antitumor immune response.
    PeÑarando J; Aranda E; RodrÍguez-Ariza A
    Transl Res; 2019 Aug; 210():99-108. PubMed ID: 30953610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.